De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
CL Overzicht aandelen
Colgate-Palmolive Company produceert en verkoopt samen met haar dochterondernemingen consumentenproducten in de Verenigde Staten en internationaal.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 5/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Strategies To Spark Revenue And Earnings Growth Amidst Global Market Challenges
Colgate-Palmolive Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$102.06 |
| 52 Week Hoogtepunt | US$109.30 |
| 52 Week Laag | US$67.62 |
| Bèta | 0.40 |
| 11 maand verandering | -4.17% |
| 3 maanden verandering | 6.43% |
| 1 Jaar Verandering | 44.64% |
| 33 jaar verandering | 35.90% |
| 5 jaar verandering | 44.50% |
| Verandering sinds IPO | 10,939.73% |
Recent nieuws en updates
Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11
Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Recent updates
Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)
May 18Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Feb 23Rendement voor aandeelhouders
| CL | US Household Products | US Markt | |
|---|---|---|---|
| 7D | -1.6% | 0.06% | -0.4% |
| 1Y | 44.6% | 18.8% | 34.1% |
Rendement versus industrie: CL overtrof de US Household Products industrie, die het afgelopen jaar een rendement 19.2 % opleverde.
Rendement versus markt: CL overtrof de US markt, die het afgelopen jaar een rendement opleverde van 33.4 %.
Prijsvolatiliteit
| CL volatility | |
|---|---|
| CL Average Weekly Movement | 2.1% |
| Household Products Industry Average Movement | 3.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: CL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 2% ) van CL is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1806 | 34,000 | Noel Wallace | www.colgatepalmolive.com |
Colgate-Palmolive Company produceert en verkoopt samen met haar dochterondernemingen consumentenproducten in de Verenigde Staten en internationaal. Het bedrijf is actief in twee segmenten: Mondverzorging, Persoonlijke Verzorging en Huishoudelijke Verzorging; en Huisdierenvoeding. Het segment Mondverzorging, Persoonlijke Verzorging en Huishoudelijke Verzorging biedt tandpasta, tandenborstels, mondwater, handzeep, douchegels, shampoos, conditioners, deodorants en antitranspiratiemiddelen, huidverzorgingsproducten, vaatwasmiddelen, wasverzachters, huishoudelijke reinigingsmiddelen en andere gerelateerde producten.
Colgate-Palmolive Company Samenvatting
| CL fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$83.61b |
| Inkomsten(TTM) | US$2.84b |
| Inkomsten(TTM) | US$19.99b |
29.4x
Koers/Winstverhouding4.2x
P/S-verhoudingIs CL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| CL resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$19.99b |
| Kosten van inkomsten | US$8.06b |
| Brutowinst | US$11.93b |
| Overige uitgaven | US$9.09b |
| Inkomsten | US$2.84b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Oct 25, 2024
| Winst per aandeel (EPS) | 3.48 |
| Brutomarge | 59.70% |
| Nettowinstmarge | 14.21% |
| Schuld/Eigen Vermogen Verhouding | 1,800.0% |
Hoe presteerde CL op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
2.0%
Huidig dividendrendement56%
UitbetalingsratioBetaalt CL een betrouwbaar dividend?
Zie CL dividendgeschiedenis en benchmarks| Colgate-Palmolive dividenddata | |
|---|---|
| Ex Dividend Datum | Oct 18 2024 |
| Betaaldatum dividend | Nov 15 2024 |
| Dagen tot Ex-dividend | 15 days |
| Dagen tot dividendbetaaldatum | 43 days |
Betaalt CL een betrouwbaar dividend?
Zie CL dividendgeschiedenis en benchmarks